A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

NCT06703606 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer